comparemela.com
Home
Live Updates
Medical Biotechnology Industry - Breaking News
Pages:
5
6
7
8
9
10
11
Latest Breaking News On - Medical biotechnology industry - Page 4 : comparemela.com
Innate Pharma Reports First Quarter 2022 Financial Results and Business Update
MARSEILLE, France (BUSINESS WIRE) May 10, 2022
United states
United kingdom
Institut paoli calmettes
Mondher mahjoubi
Bristol myers squibb
Novo nordisk
French financial markets authority
Company annual report on form
Exchange commission
American association for cancer research
Lymphoma study association
European society for medical oncology
Euronext paris
Chief executive officer
Innate pharma
Company sponsored phase
Amylyx Pharmaceuticals Reports Full Year 2021 Financial Results
CAMBRIDGE, Mass. (BUSINESS WIRE) Mar 30, 2022
United states
United kingdom
Becky gohsler
Josh cohen
Justin klee
Seanm healey
James frates
Chris aiello
Paul fonteyne
Lindsey allen
Daphne quimi
Amylyx pharmaceuticals inc
Central nervous system drugs advisory committee
Leandrop rizzuto foundation
Drug administration
Science committee
AVM Biotechnology Expands C-Suite in Anticipation of 2023 Commercialization Efforts
SEATTLE (BUSINESS WIRE) Mar 9, 2022
United states
Joe luminiello
Pearl chan
Jena dalpez
Brian andersen
Northwestern university kellogg school of management
Netmotion software
University of washington
University of illinois at urbana champaign
Business development
Natural killert like
Chief commercial officer
Chief financial
Business wire
Vidara therapeutics
Northwestern university
LYNPARZA® (olaparib) approved in the US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
WILMINGTON, Del. (BUSINESS WIRE) Mar 11, 2022
United states
United kingdom
City of
Dave fredrickson
Jessica mcduell
Daiichi sankyo
Andrew tutt
Brendan mcevoy
Roy baynes
King college london
Breast cancer research
Merck research laboratories
American society of clinical oncology
Union for international cancer
Drug administration
Us national cancer institute
Gene-edited beef cattle get regulatory clearance in US
NEW YORK (AP) — U.S. regulators on Monday cleared the way for the sale of beef from gene-edited cattle in coming years after the Food and Drug Administration concluded the
United states
Steven solomon
Alison van eenennaam
Jaydee hanson
Greg jaffe
University of california
Science department
Drug administration
Associated press
Veterinary medicine
Public interest
Food safety
Van eenennaam
Associated press health
Howard hughes medical institute
Ene edited cattle
vimarsana © 2020. All Rights Reserved.